Related Experiment Video
Updated: Aug 26, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2
Flavio Bruni1, Panteleimon Charitos1, Maurin Lampart2
1Division of Internal Medicine, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Insights
COVID-19 patients show over-activated complement and endothelial cells compared to controls. This "over-activation" of thromboinflammation markers like C5a and VCAM-1 is linked to severe outcomes and sex differences in COVID-19.
Area of Science:
- * Immunology
- * Cardiovascular Medicine
- * Infectious Diseases
Background:
- * Thromboinflammation is implicated in COVID-19 disease severity.
- * Understanding complement and endothelial activation is crucial for COVID-19 patient outcomes.
Purpose of the Study:
- * To evaluate complement and endothelial cell activation in COVID-19 patients.
- * To compare activation markers between COVID-19 cases and controls with suspected but excluded SARS-CoV-2 infection.
Main Methods:
- * Prospective, observational, single-center study.
- * Recruitment of patients in the emergency department with suspected COVID-19.
- * Analysis of C5a, sC5b-9, E-selectin, Galectin-3, ICAM-1, and VCAM-1 in blood samples.
Main Results:
- * COVID-19 patients exhibited significantly elevated C5a and VCAM-1, and decreased E-selectin compared to controls.
- * Elevated C5a, Galectin-3, ICAM-1, and VCAM-1 were associated with ICU admission or 30-day mortality, particularly in COVID-19 patients.
- * COVID-19 males showed higher C5a and sC5b-9 levels than females, unlike controls.
Conclusions:
- * COVID-19 is associated with complement cascade and endothelial activation beyond non-specific inflammation.
- * This
Background:
Thromboinflammation may influence disease outcome in COVID-19. We aimed to evaluate complement and endothelial cell activation in patients with confirmed COVID-19 compared to controls with clinically suspected but excluded SARS-CoV-2 infection.
Methods:
In a prospective, observational, single-center study, patients presenting with clinically suspected COVID-19 were recruited in the emergency department. Blood samples on presentation were obtained for analysis of C5a, sC5b-9, E-selectin, Galectin-3, ICAM-1 and VCAM-1.
Results:
153 cases and 166 controls (suffering mainly from non-SARS-CoV-2 respiratory viral infections, non-infectious inflammatory conditions and bacterial pneumonia) were included. Hospital admission occurred in 62% and 45% of cases and controls, respectively. C5a and VCAM-1 concentrations were significantly elevated and E-selectin concentrations decreased in COVID-19 out- and inpatients compared to the respective controls. However, relative differences in outpatients vs. inpatients in most biomarkers were comparable between cases and controls. Elevated concentrations of C5a, Galectin-3, ICAM-1 and VCAM-1 on presentation were associated with the composite outcome of ICU- admission or 30-day mortality in COVID-19 and controls, yet more pronounced in COVID-19. C5a and sC5b-9 concentrations were significantly higher in COVID-19 males vs. females, which was not observed in the control group.
Conclusions:
Our data indicate an activation of the complement cascade and endothelium in COVID-19 beyond a nonspecific inflammatory trigger as observed in controls (i.e., "over"-activation).
More Related Videos
07:56Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
12:50Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Related Concept Videos
Complement System
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...